$150 Million 'Powerhouse:' California Discloses Financing Details on New Stem Cell Company
CIRM graphic
Highlights
A California first
De-risking therapy development
Selling off the notes
Possible IPO
California's stem cell agency this week unveiled details of a far-reaching and unique proposal to create a $150 million, public-private company to speed commercialization of stem cell therapies and bring them into widespread use.
The proposal by the Ca…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.